This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Bortezomib
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1022872/Cv/1'> |
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.<ref name="a2">[https://www.drugs.com/monograph/bortezomib.html "Bortezomib Monograph for Professionals".] Drugs.com. Retrieved 13 October 2019.</ref> This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications.<ref name="a3">[https://www.ema.europa.eu/en/medicines/human/EPAR/velcade "Velcade".] European Medicines Agency (EMA). 17 September 2018. Retrieved 13 October 2019.</ref> | Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.<ref name="a2">[https://www.drugs.com/monograph/bortezomib.html "Bortezomib Monograph for Professionals".] Drugs.com. Retrieved 13 October 2019.</ref> This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications.<ref name="a3">[https://www.ema.europa.eu/en/medicines/human/EPAR/velcade "Velcade".] European Medicines Agency (EMA). 17 September 2018. Retrieved 13 October 2019.</ref> | ||
Revision as of 12:55, 15 January 2024
| |||||||||||
References
- ↑ "Bortezomib Monograph for Professionals". Drugs.com. Retrieved 13 October 2019.
- ↑ "Velcade". European Medicines Agency (EMA). 17 September 2018. Retrieved 13 October 2019.
